Hodgkin lymphoma statistics

Cases

New cases of Hodgkin lymphoma, 2011, UK

Deaths

Deaths from Hodgkin lymphoma, 2012, UK

Survival

Survive Hodgkin lymphoma for 10 or more years, 2010-11, England and Wales

Prevention

Preventable cases of Hodgkin lymphoma, UK

  • Around 1,800 people were diagnosed with Hodgkin lymphoma in 2011 in the UK, that’s around 5 people every day.
  • Hodgkin lymphoma can develop at any age, but there are two peaks in incidence – in young adults, and older men and women.
  • 1 in 10 Hodgkin lymphomas are diagnosed in people aged 75 and over.
  • Around 1 in 5 Hodgkin lymphoma cases occur in children, teenagers and young adults (up to age 24).
  • Overall, Hodgkin lymphoma incidence rates have remained stable for males and increased for females since the mid-1970s, though for both sexes there was a decrease from the mid-1970s until the 1990s, followed by an increase to the present.
  • Most Hodgkin lymphoma cases are diagnosed at an early stage.
  • Worldwide there were estimated to be around 68,000 new cases of Hodgkin lymphoma in 2008, and more than half of these were in developing countries.

Read more in-depth Hodgkin lymphoma incidence statistics

  • More than a third of Hodgkin lymphoma deaths occur in people aged 75 and over.
  • In the UK there were more than 330 deaths from Hodgkin lymphoma in 2012, that is more than 6 people every week.
  • Hodgkin lymphoma death rates in the UK have fallen by 75% over the last forty years.
  • Worldwide, around 25,500 people were estimated to have died from Hodgkin lymphoma in 2012, with mortality rates varying across the world.
  • In Europe, around 4,600 people were estimated to have died from Hodgkin lymphoma in 2012. The UK mortality rate is 19th lowest in Europe for males and 13th highest for females.

Read more in-depth Hodgkin lymphoma mortality statistics

  • 8 in 10 (80%) people diagnosed with Hodgkin lymphoma in England and Wales survive their disease for ten years or more (2010-11).
  • Almost 9 in 10 (85%) people diagnosed with Hodgkin lymphoma in England and Wales survive their disease for five years or more (2010-11).
  • Around 9 in 10 (91%) people diagnosed with Hodgkin lymphoma in England and Wales survive their disease for one year or more (2010-11).
  • Hodgkin lymphoma survival is higher in women than men.
  • Hodgkin lymphoma survival is highest for people diagnosed aged under 40 years old.
  • 95% of people diagnosed aged 15-39 survive their disease for five years or more, compared with less than a third of people diagnosed aged 80 and over.
  • Hodgkin lymphoma survival is improving and has increased in the last 40 years in the UK.
  • In the 1970s, almost half of people diagnosed with Hodgkin lymphoma survived their disease beyond ten years, now it's 8 in 10.

Read more in-depth Hodgkin lymphoma survival statistics

  • 45% of Hodgkin lymphoma cases each year in the UK are linked to major lifestyle and other risk factors.
  • A person’s risk of developing Hodgkin lymphoma depends on many factors, including age, genetics, and exposure to risk factors (including some potentially avoidable lifestyle factors).
  • Evidence on Hodgkin lymphoma risk factors is limited, mainly because this cancer is relatively rare and comprises many subtypes.
  • Epstein-Barr virus is the main potentially avoidable risk factor for Hodgkin lymphoma, linked to an estimated 45% of Hodgkin lymphoma cases in the UK.
  • Human immunodeficiency virus (HIV) causes Hodgkin lymphoma.
  • Problems with the immune system, overweight and obesity, and smoking may relate to higher Hodgkin lymphoma risk.

Read more in-depth Hodgkin lymphoma risk factors

Want these Key Stats as a document or looking for a stats report?
Use the print function at the bottom of any page Share this page > +Other > Print or through your browser options to print or save these stats.

The latest statistics available for Hodgkin lymphoma in the UK are; incidence 2011, mortality 2012 and survival 2010-2011.

The ICD code Open a glossary item for Hodgkin lymphoma is ICD-10 C81.

Survival statistics give an overall picture of survival and (unless otherwise stated) include all adults (15-99) diagnosed, at all ages, stages Open a glossary item and co-morbidities . The survival time experienced by an individual patient may be much higher or lower, depending on specific patient and tumour characteristics.

Overall, the evidence on Hodgkin lymphoma risk factors is limited, mainly because of this cancer's relative rarity and diversity. Studies which group together different morphological subtypes of Hodgkin lymphoma may be confounded if those subtypes have differing aetiologies.

Meta-analyses Open a glossary item and systematic reviews Open a glossary item are cited where available, as they provide the best overview of all available research and most take study quality into account. Individual case-control and cohort Open a glossary item studies are reported where such aggregated data are lacking.

Routes to diagnosis statistics were calculated from cases of cancer registered in England which were diagnosed in 2006-2010.

Cancer waiting times statistics are for patients who entered the health care system within financial year 2014-15. Hodgkin lymphoma is part of the group 'Haematological cancers' for cancer waiting times data. Codes vary per country but broadly include: Hodgkin lymphoma, follicular and non-follicular lymphoma, mature T/NK-cell lymphoma, other and unspecified types of NHL, other and unspecified types of T/NK-cell lymphoma, malignant immunoproliferative diseases, myeloma, lymphoid, myeloid and monocytic leukaemia, some other leukaemia of specific or unspecified cell type, and other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue.

Citation

You are welcome to reuse this Cancer Research UK statistics content for your own work.

Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:

Web content: Cancer Research UK, full URL of the page, Accessed [month] [year]. 

Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK. 

Acknowledgements

We would like to acknowledge the essential work of the cancer registries in the United Kingdom and Ireland Association of Cancer Registries, without which there would be no data.

Rate this page:

Currently rated: 5 out of 5 based on 1 vote
Thank you!
We've recently made some changes to the site, tell us what you think

Share this page